Biomarkers of renal function in prognostic stratification of patients with acute coronary syndrome

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F18%3A73592013" target="_blank" >RIV/61989592:15110/18:73592013 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00098892:_____/18:N0000106

Výsledek na webu

<a href="https://e-coretvasa.cz/pdfs/cor/2018/02/20.pdf" target="_blank" >https://e-coretvasa.cz/pdfs/cor/2018/02/20.pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2017.05.018" target="_blank" >10.1016/j.crvasa.2017.05.018</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Biomarkers of renal function in prognostic stratification of patients with acute coronary syndrome

Popis výsledku v původním jazyce

There is close pathophysiological interaction between the kidneys and the heart, affecting, among others, the risk for development and prognosis of many cardiovascular disease. Early risk stratification of patients with acute coronary syndrome (ACS) is important for optimizing their therapy. Presented is an overview of prognostic stratification of ACS patients according to baseline levels of renal function biomarkers. Apart from classic biomarkers (creatinine, urea) having a dominant role in advanced chronic kidney disease, some novel biomarkers are listed (cystatin C, neutrophil gelatinase-associated lipocalin, interleukin-18) that bring an added value as they are directly associated with the pathological mechanisms of the course of ACS. (c) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. z o. o. All rights reserved.

Název v anglickém jazyce

Biomarkers of renal function in prognostic stratification of patients with acute coronary syndrome

Popis výsledku anglicky

There is close pathophysiological interaction between the kidneys and the heart, affecting, among others, the risk for development and prognosis of many cardiovascular disease. Early risk stratification of patients with acute coronary syndrome (ACS) is important for optimizing their therapy. Presented is an overview of prognostic stratification of ACS patients according to baseline levels of renal function biomarkers. Apart from classic biomarkers (creatinine, urea) having a dominant role in advanced chronic kidney disease, some novel biomarkers are listed (cystatin C, neutrophil gelatinase-associated lipocalin, interleukin-18) that bring an added value as they are directly associated with the pathological mechanisms of the course of ACS. (c) 2017 The Czech Society of Cardiology. Published by Elsevier Sp. z o. o. All rights reserved.

Druh

J_SC - Článek v periodiku v databázi SCOPUS

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2018

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

COR ET VASA

ISSN

0010-8650

e-ISSN

—

Svazek periodika

60

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

7

Strana od-do

"E148"-"E154"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

2-s2.0-85021324663